Connecting to the GLP-1 Patient Specifically A GLP-1 patient in active weight loss is experiencing two concurrent cellular deficits: declining dermal collagen production from subcutaneous volume loss compounded by age-related fibroblast slowdown, and declining muscle mass from sustained caloric deficit
That year 390 million children and adolescents aged 5-19 were thought to be overweight, of whom 160 million were obese (WHO 2024)
GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in the intestines and plays a key role in regulating blood sugar levels and controlling appetite
Using Zepbound: Dosage and Administration Zepbound is administered via once-weekly subcutaneous injections, generally in areas like the abdomen, thigh, or upper arm
Each of these volunteers fasted overnight and randomly received infusions of saline water with or without GLP-1 (7-36) or with or without GIP and their levels of insulin in plasma measured after receiving oral glucose and a test breakfast
Compounded drugs are custom medications prepared by pharmacies to meet specific patient needs